Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Culture Model Technology Designed to Improve Cancer Research

By LabMedica International staff writers
Posted on 27 Aug 2009
An Australian researcher, who has devised a three-dimensional (3D) technology platform for biomedical research, has received early-stage funding to accelerate the process of development to commercialization.

Prof. More...
Dietmar W. Hutmacher, a researcher with Queensland University of Technology's (QUT) Institute of Health and Biomedical Innovation (IHBI; Brisbane, Australia), reported that he hoped the 3D culture models developed could be used by pharmaceutical companies and research laboratories to enhance testing of treatments within a variety of areas, including cancer research. "The culture system could potentially be used during all forms of cancer research, as well as infectious diseases, and basically any field which relies on cell cultures as a platform for the discovery of new drugs, or to test new treatments,” he said. "It is a logical and practical tool which can really help researchers to get results which reflect much better what is going on in the body.”

Prof. Hutmacher has spent the past 12 months developing and improving scaffolds and matrices for the 3D cell culture, and it has already been used in a number of IHBI research projects. The tissue-engineered constructs and hydrogels mimic the body's biologic tissues, and provide a model to analyze the interactions and stresses that cells experience.

The cell culture can be used in experiments in cancer research, immunology, and infectious diseases to predict more effectively the effect on the body than conventional two-dimensional (2D) culture. "Almost everything in the human body is 3D, so having a 3D cell culture system to test in makes it more realistic than the traditional 2D culture models which are widely used in the biomedical sciences,” said Prof. Hutmacher. "We want to mimic what the cells see and feel inside the human body, so that the environment researchers are testing closely match that of the actual human body.”

The US$99,000 funding is a Proof of Concept investment from QUT's commercialization arm bluebox , and will be used to accelerate the design of new scaffolds built by electrospinning techniques to enhance its features and make it more user-friendly.

Prof. Hutmacher, who saw another project through to commercialization when he was working in Singapore, stated that it was always exciting to be part of the journey from the bench to the market. "I think it is great that QUT has the Proof of Concept fund, which allows researchers to go a step further and think about ways to get their ideas and ultimately their products developed.”

Prof. Hutmacher reported that he is in the process of looking for other cancer or immunology researchers in Brisbane or throughout Australia who would like to collaborate with him on this 3D culture model.

Related Links:
QUT Institute of Health and Biomedical Innovation






Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.